Life360, Inc.·4

Mar 17, 4:34 PM ET

Prober Charles J. 4

4 · Life360, Inc. · Filed Mar 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Life360 (LIF) Director Charles J. Prober Exercises Options, Sells Shares

What Happened Charles J. Prober, a director of Life360 (LIF), exercised 7,930 stock options on March 13, 2026 at an exercise price of $11.18 per share (cost $88,657) and immediately sold 7,930 shares in an open-market transaction at $41.40 per share (gross proceeds $328,302). The Form 4 also reports a derivative disposition for 7,930 shares at $0, consistent with conversion/exercise of the option. Net of the exercise cost, the transaction produced a gross difference of about $239,645 before taxes and fees. These trades were executed under a pre-established Rule 10b5-1 plan.

Key Details

  • Transaction date: March 13, 2026 (filed March 17, 2026; filing appears within the normal Form 4 timeframe)
  • Exercise: 7,930 shares at $11.18 — total cost $88,657
  • Sale: 7,930 shares at $41.40 — gross proceeds $328,302
  • Derivative note: 7,930 shares reported disposed at $0 (reflects the option conversion/exercise)
  • Net change to beneficial ownership from these transactions: zero (7,930 acquired, 7,930 sold)
  • Footnotes: F1 — sale effected under a Rule 10b5-1 trading plan adopted March 14, 2025; F2 — holdings include 679 RSUs previously granted; F3 — option vesting schedule described (partial vesting starting April 1, 2024)

Context This was an exercise of stock options followed by an immediate open-market sale (a cashless-style transaction). The sale was carried out under a pre-established 10b5-1 plan, which is a routine mechanism insiders use to sell shares according to predetermined rules and not necessarily an indication of a change in outlook. The filing shows no net increase in shares held by the director from these entries.

Insider Transaction Report

Form 4
Period: 2026-03-13
Transactions
  • Exercise/Conversion

    Common stock

    [F1][F2]
    2026-03-13$11.18/sh+7,930$88,657113,386 total
  • Sale

    Common stock

    [F1][F2]
    2026-03-13$41.40/sh7,930$328,302105,456 total
  • Exercise/Conversion

    Stock Option (right to buy)

    [F1][F3]
    2026-03-137,93063,440 total
    Exercise: $11.18Exp: 2028-04-12Common stock (7,930 underlying)
Footnotes (3)
  • [F1]The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  • [F2]Includes 679 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  • [F3]The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the remaining shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date
Signature
/s/ Jay Sood, Attorney-in-Fact|2026-03-17

Documents

1 file
  • 4
    wk-form4_1773779682.xmlPrimary

    FORM 4